Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide in active ulcerative colitis
NCT00463151Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rebamipide in ulcerative colitis (UC), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jun 2007; status: completed.
02
Drugs
rebamipide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00463151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463151.